Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Infiltrating Blood-Derived Macrophages Are Vital Cells Playing An Anti-inflammatory Role In Recovery From Spinal Cord Injury In Mice
Although macrophages are known as essential players in wound healing,

Huntington's: Researchers Gain Insight Into Mechanism Underlying The Disease
Researchers at the University of Kentucky Markey Cancer Center and Graduate Center for Toxicology (GCT) have gained new insight into the genetic mechanisms underlying Huntington"s disease and other neurodegenerative or neuromuscular disorders caused by trinucleotide repeats (or TNRs) in DNA.
News of the day
Youth Baseball-Related Injuries Down 25 Percent, National Study Finds
Spring marks baseball season for more than 19 million children and adolescents who play each year as part of a team or in backyards throughout the United States. The good news for these players is that the number of injuries from the sport is on the decline. A new study by the Center for Injury Research and Policy of The Research Institute at Nationwide Children"s Hospital found that the number of children and adolescents treated for baseball-related injuries in hospital emergency departments decreased 25 percent from 1994 through 2006 - going from an estimated 147,000 injuries in 1994 to approximately 111,000 injuries in 2006. This is the first national study of youth baseball injuries requiring emergency treatment, and is now available online in the June electronic issue of Pediatrics.
Diagnostics

Indian Authorities Asked To Stop Licensing Artemisinin-Only Malaria Drugs

The Drugs Controller General of India (DCGI) asked state drug licensing authorities to avoid authorizing new licenses for single drug formulations of artemisinin and withdraw existing licences for these types of drugs by the end of this month, livemint.com reports. To prevent drug resistance, the WHO has advised against the use of drugs that only contain artemisinin to treat malaria and recommends using artemsinin in combination with other drugs. "India"s drug advisory body, the drug consultative committee, had in December approved the phasing out of the [artemisinin only] drug[s] from the market," livemint.com writes. H.G. Koshia, the commissioner of the food and drug control administration for the state of Gujarat, said, "The state department has received the last directive in this regard a couple of weeks ago, and we have already informed all existing licence holders to stop manufacturing. The brand recalls from the market is also in progress, though there aren"t many at present." According to livemint.com: "Ipca Laboratories Ltd., Themis Medicare Ltd., Plethico Pharmaceuticals Ltd., GVS Laboratories Ltd., Cipla and Lupin Ltd. are some of the top firms in the domestic anti-malaria market. These are also key suppliers to overseas markets through [the] WHO or direct channels, and most have already stopped making the product following [the] WHO"s warning on single oral therapy using artemisinin and its derivatives." R.B. Smartha, the managing director of Mumbai-based Interlink Marketing Consultancy Pvt. Ltd., said, "The impact of the DCGI order would not be big for the industry as the market for oral single formulation of artemisinin derivatives has already shrunk" (Pandeya/Unnikrishnan, 7/22). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009